These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro. Brophy TM; Ward SE; McGimsey TR; Schneppenheim S; Drakeford C; O'Sullivan JM; Chion A; Budde U; O'Donnell JS Arterioscler Thromb Vasc Biol; 2017 May; 37(5):845-855. PubMed ID: 28279966 [TBL] [Abstract][Full Text] [Related]
10. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha. Martin C; Morales LD; Cruz MA J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010 [TBL] [Abstract][Full Text] [Related]
11. In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion. Da Q; Han H; Valladolid C; Fernández M; Khatlani T; Pradhan S; Nolasco J; Matsunami RK; Engler DA; Cruz MA; Vijayan KV J Thromb Haemost; 2019 Jun; 17(6):866-877. PubMed ID: 30864273 [TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivo. Tang L; Leong L; Sim D; Ho E; Gu JM; Schneider D; Feldman RI; Monteclaro F; Jiang H; Murphy JE Haemophilia; 2013 Jul; 19(4):539-45. PubMed ID: 23534820 [TBL] [Abstract][Full Text] [Related]
13. The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding. Parker DN; Tasneem S; Farndale RW; Bihan D; Sadler JE; Sebastian S; de Groot PG; Hayward CP Thromb Haemost; 2016 Jul; 116(1):87-95. PubMed ID: 27052467 [TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease. Jenkins PV; Pasi KJ; Perkins SJ Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease. Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947 [TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in vivo. Rawley O; O'Sullivan JM; Chion A; Keyes S; Lavin M; van Rooijen N; Brophy TM; Fallon P; Preston RJ; O'Donnell JS J Thromb Haemost; 2015 May; 13(5):821-6. PubMed ID: 25690668 [TBL] [Abstract][Full Text] [Related]
17. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib. Obert B; Houllier A; Meyer D; Girma JP Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669 [TBL] [Abstract][Full Text] [Related]
18. Increased galactose expression and enhanced clearance in patients with low von Willebrand factor. Aguila S; Lavin M; Dalton N; Patmore S; Chion A; Trahan GD; Jones KL; Keenan C; Brophy TM; O'Connell NM; Ryan K; Byrne M; Nolan M; Patel A; Preston RJS; James P; Di Paola J; O'Sullivan JM; O'Donnell JS Blood; 2019 Apr; 133(14):1585-1596. PubMed ID: 30770394 [TBL] [Abstract][Full Text] [Related]
19. Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction. De Cristofaro R; Peyvandi F; Baronciani L; Palla R; Lavoretano S; Lombardi R; Di Stasio E; Federici AB; Mannucci PM J Biol Chem; 2006 Oct; 281(41):30400-11. PubMed ID: 16899464 [TBL] [Abstract][Full Text] [Related]
20. Conformational stability and domain unfolding of the Von Willebrand factor A domains. Auton M; Cruz MA; Moake J J Mol Biol; 2007 Feb; 366(3):986-1000. PubMed ID: 17187823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]